Navigation Links
Biodefense Industry Response to New WMD Report Card
Date:1/26/2010

ANNAPOLIS, Md., Jan. 26 /PRNewswire-USNewswire/ -- The following is a statement by David Wright, President and CEO of PharmAthene, regarding the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism Report Card:

Today's Report Card by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism sends a dire warning that America still remains vulnerable to bioterrorism.  Our Nation's ability to prevent and respond to a bioterrorist attack received an abysmal grade – 'F'. This is entirely unacceptable, especially when we have the solutions.  We have next generation medical countermeasures for anthrax that are languishing without adequate funding to ensure their procurement; we have leaders like Senators Graham and Talent, and many others, who are passionately dedicated to preventing WMD proliferation and terrorism.  As the Report Card makes clear, we need increased funding, more accountability, and less fragmented decision-making.   We have the answers and the solutions—it is imperative that we execute.  PharmAthene is committed to working with our partners in government to implement the solutions, and applauds Senators Graham and Talent for their leadership and dedication to this cause.

SOURCE PharmAthene


'/>"/>
SOURCE PharmAthene
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
2. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
3. HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
4. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
5. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
6. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
7. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
8. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
9. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
10. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
11. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):